Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | F. L. Locke, S. S. Neelapu, N. L. Bartlett, L. J. Lekakis, D Miklos, C. A. Jacobson, I. Braunschweig, O. Oluwole, T. Siddiqi, Y. Lin, J. Timmerman, J. W. Friedberg, A. Bot, J. Rossi, L. Navale, Y. Jiang, J. Aycock, M. Elias, J. Wiezorek and W. Y. Go | ||||||||||||
Title | Primary results from ZUMA-1: a pivotal trial of axicabtagene ciloleucel (axicel; KTE-C19) in patients with refractory aggressive non-Hodgkin lymphoma (NHL) | ||||||||||||
|
|||||||||||||
URL | http://cancerres.aacrjournals.org/content/77/13_Supplement/CT019 | ||||||||||||
Abstract Text | Cancer Res 2017;77(13 Suppl):Abstract nr CT019 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|